A detailed history of Franklin Resources Inc transactions in Rhythm Pharmaceuticals, Inc. stock. As of the latest transaction made, Franklin Resources Inc holds 232,677 shares of RYTM stock, worth $12.8 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
232,677
Previous 220,905 5.33%
Holding current value
$12.8 Million
Previous $9.57 Million 0.19%
% of portfolio
0.0%
Previous 0.0%

Shares

10 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$35.41 - $44.37 $416,846 - $522,323
11,772 Added 5.33%
232,677 $9.55 Million
Q1 2024

May 13, 2024

BUY
$39.12 - $52.44 $8.41 Million - $11.3 Million
215,029 Added 3659.45%
220,905 $9.57 Million
Q4 2023

Feb 09, 2024

BUY
$21.39 - $49.64 $125,687 - $291,684
5,876 New
5,876 $270,000
Q2 2022

Aug 11, 2022

BUY
$3.12 - $12.25 $34 - $134
11 Added 0.0%
1,779,465 $7.39 Million
Q1 2022

May 13, 2022

BUY
$6.13 - $12.24 $1.49 Million - $2.97 Million
242,582 Added 15.78%
1,779,454 $20.5 Million
Q4 2021

Feb 11, 2022

BUY
$8.62 - $13.9 $11.8 Million - $19 Million
1,368,789 Added 814.35%
1,536,872 $15.3 Million
Q3 2021

Nov 12, 2021

BUY
$11.68 - $20.72 $1.96 Million - $3.48 Million
168,083 New
168,083 $2.2 Million
Q2 2018

Aug 14, 2018

SELL
$17.02 - $35.2 $1.84 Million - $3.8 Million
-107,900 Closed
0 $0
Q1 2018

May 10, 2018

SELL
$19.9 - $32.25 $2.77 Million - $4.48 Million
-139,000 Reduced 56.3%
107,900 $2.15 Million
Q4 2017

Feb 14, 2018

BUY
$22.0 - $30.51 $5.43 Million - $7.53 Million
246,900
246,900 $7.18 Million

Others Institutions Holding RYTM

About RHYTHM PHARMACEUTICALS, INC.


  • Ticker RYTM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 55,720,000
  • Market Cap $3.06B
  • Description
  • Rhythm Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of therapeutics for the treatment of rare genetic diseases of obesity. The company's lead product candidate is IMCIVREE, a potent melanocortin-4 receptor for the treatment of pro-opiomelanocortin (POMC), proprotein convert...
More about RYTM
Track This Portfolio

Track Franklin Resources Inc Portfolio

Follow Franklin Resources Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Franklin Resources Inc, based on Form 13F filings with the SEC.

News

Stay updated on Franklin Resources Inc with notifications on news.